VARNOLINE CONTINU, film-coated tablet 21 tablets
Active ingredients: DÉSOGESTREL, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet21 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VARNOLINE CONTINU, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 plaquette(s) thermoformée(s) PVC aluminium de 21 comprimés blancs et de 7 comprimés verts
- Marketing authorisation holder
- ORGANON FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Nov 1995
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69797801CIP73385383CIP133400933853839Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLcomprimé blanc | 0,030 mg · un comprimé | SA |
| DÉSOGESTRELcomprimé blanc | 0,150 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.